Lapinig, Mary Jane L.
HRN: 24-57-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2024
CEFUROXIME 500MG (TAB)
02/17/2024
02/24/2024
PO
500mg
BID
S/P NSVD, IUFD Macerated
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes